Hostname: page-component-586b7cd67f-l7hp2 Total loading time: 0 Render date: 2024-11-26T19:54:35.463Z Has data issue: false hasContentIssue false
  • English
  • Français

Correcting drug-induced hyperprolactinaemia

Published online by Cambridge University Press:  02 January 2018

G. W. Mercer  and
A. H. Young
G. W. Mercer
Affiliation:
School of Neurosciences, University of Newcastle, Division of Psychiatry, The Royal Victoria Infirmary, Newcastle upon Tyne NE1 4LP
A. H. Young
Affiliation:
School of Neurosciences, University of Newcastle, Division of Psychiatry, The Royal Victoria Infirmary, Newcastle upon Tyne NE1 4LP
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Information
Psychiatric Bulletin , Volume 20 , Issue 8 , August 1996 , pp. 499 - 500
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © Royal College of Psychiatrists, 1996

References

Jann, M. W., Grimsley, S. R., Gray, E. C., et al (1993) Pharmacokinetics and pharmacodynamics of clozapine. Clinical Pharmacokinetics, 24, 161–176.Google Scholar
Meltzer, H. Y. & Fang, V. S. (1976) Serum prolactin levels in schizophrenia – effect of antipsychotic drugs: a preliminary report. In Hormones, Behavior and Psychopathology (ed. Sachar, E. J.), pp. 178–191. New York: Raven Press.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.